Nutrition Research
Volume 23, Issue 1 , Pages 15-26 , January 2003

Long-term effect of reduced carbohydrate or increased fiber intake on LDL particle size and HDL composition in subjects with type 2 diabetes

  • Thomas M.S Wolever

      Affiliations

    • Department of Nutritional Sciences, University of Toronto, St. Michael’s Hospital, Toronto, ON, Canada (TMSW, ET)
    • Division of Endocrinology and Metabolism, St. Michael’s Hospital, Toronto, ON, Canada (TMSW)
    • Corresponding Author InformationCorresponding author. Tel: +1-416-978-5556; fax: +1-416-978-5882.
    • ,
  • Elizabeth B Tsihlias

      Affiliations

    • Department of Nutritional Sciences, University of Toronto, St. Michael’s Hospital, Toronto, ON, Canada (TMSW, ET)
    • ,
  • Michael I McBurney

      Affiliations

    • Kellogg Company, Battle Creek, MI, USA (MIM)
    • Michael McBurney is an employee of the Kellogg Company.
    • ,
  • Ngoc-Anh Le

      Affiliations

    • Lipid Research Laboratory, Emory/Atlanta VAMC Lipid Research Program, Atlanta, GA, USA (N-AL)

Received 26 April 2002 ,Revised 4 October 2002 ,Accepted 6 October 2002.

References 

  1. Garg A. High-monounsaturated-fat diets for patients with diabetes mellitus (a meta-analysis). Am J Clin Nutr. 1998;67(suppl):577S–582S
  2. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willeft WS, Krauss RM. Low density lipoprotein subclass patterns and risk of myocardial infraction. JAMA. 1988;260:1917–1924
  3. Austin MA, Kind MC, Vranizian KM, Krauss RM. Atherogenic lipoprotein phenotype (a proposed genetic marker for coronary heart disease). Circulation. 1990;82:495–506
  4. Lamarche B, Tchernof A, Moorjani S, Cantin B, Dagenais GR, Lupien PJ, et al. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men (Prospective results from the Quebec cardiovascular study). Circulation. 1997;95:69–75
  5. Kamigaki AS, Siscovick DS, Schwartz SM, Psaty BM, Edwards KL, Rahunathan TE, et al. Low density lipoprotein particle size and risk of early-onset myocardial infarction in women. Am J Epidemiol. 2001;153:939–945
  6. Dreon DM, Ferstrom HA, Miller B, Krauss RM. Apolipoprotein E isoform phenotype and LDL subclass response to a reduced-fat diet. Arterioscl Thromb Vasc Biol. 1995;15:105–111
  7. Beard CM, Barnard RJ, Robbins DC, Ordovas JM, Schaefer EJ. Effects of diet and exercise on qualitative and quantitative measured of LDL and its susceptibility to oxidation. Arterioscl Thomb Vasc Biol. 1996;16:201–207
  8. Kasim-Karakas SE, Lane E, Almario R, Mueller W, Walzem R. Effects of dietary fat restriction on particle size of plasma lipoproteins in postmenopausal women. Metabolism. 1997;46:431–436
  9. Brinton EA, Eisenberg S, Breslow JL. Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia. J Clin Invest. 1991;87:536–544
  10. Durrington PN. How HDL protects against atheroma. Lancet. 1993;342:1315–1316
  11. Lamarche B, Uffelman KD, Carpentier A, Cohn JS, Steiner G, Barrett PH, et al. Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men. J Clin Invest. 1999;103:1191–1199
  12. Tall AR. Plasma cholesteryl ester transfer protein and high-density lipoproteins (new insights from molecular genetic studies). J Intern Med. 1995;237:5–12
  13. Le NA, Gibson JC, Ginsberg HN. Independent regulation of plasma apolipoprotein C-II and C-III concentrations in very low density and high density lipoproteins (implications for the regulation of the catabolism of these lipoproteins). J Lipid Res. 1988;29:669–677
  14. Hodis HN, Mack WJ. Triglyceride-rich lipoproteins and the progression of coronary heart disease. Curr Opin Lipidol. 1995;6:209–214
  15. Reaven GM, Chen YDI, Jeppesen J, Maheux P, Krauss RM. Insulin resistance and hyperinsulinemia in individuals with small dense low density lipoprotein particles. J Clin Invest. 1993;92:141–146
  16. Haffner SM, Mykkanen L, Robbins D, Valdez R, Miettinen H, Howard BV, et al. A preponderance of small dense LDL is associated with specific insulin, proinsulin and the components of the insulin resistance syndrome in non-diabetic subjects. Diabetologia. 1995;38:1328–1336
  17. Ambrosch A, Muhlen I, Kopf D, Augustin W, Dierkes J, Konig W, et al. Lehnert H. LDL size distribution in relation to insulin sensitivity in lipoprotein pattern in young and healthy subjects. Diabetes Care. 1998;21:2077–2084
  18. Barakat HA, Carpenter JW, McLendon VD. Influence of obesity, impaired glucose tolerance and NIDDM on LDL structure and composition (possible link between hyperinsulinemia and atherosclerosis). Diabetes. 1990;39:1527–1533
  19. Tsihlias EB, Gibbs AL, McBurney MI, Wolever TMS. Comparison of high- and low-glycemic index breakfast cereals versus monounsaturated fat in the long-term dietary management of type 2 diabetes. Am J Clin Nutr. 2000;72:439–449
  20. The lipid research clinics population studies data book. Volume II. The prevalence study-nutrient intake. Washington, DC, U.S. Department of Health and Human Services, 1982 (NIH Publication No. 82-2014)
  21. Composition of Foods. Agriculture Handbook no. 8. Washington, DC, U.S. Department of Agriculture, 1992
  22. Li X, Innis-Whitehouse W, Brown WV, Le NA. Protocol for the preparation of a segmental linear polyacrylamide gradient gel (simultaneous determination of Lp(a), LDL and HDL particle sizes). J Lipid Res. 1997;38:2603–2614
  23. Motulsky H, Intuitive Biostatistics. New York: Oxford University Press, 1995. p. 250-1.
  24. Sniderman AD, Cianflone K, Arner P, Summers LKM, Frayn KN. The adipocyte, fatty acid trapping and atherogenesis. Arterioscler Thromb Vasc Biol. 1998;18:147–151
  25. Laws A, Hoen HM, Selby JV, Haffner SM, Howard BV. Differences in insulin suppression of free fatty acid levels by gender and glucose tolerance status (relations to plasma triglyceride and apolipoprotein B concentrations). Arteriosler Thromb Vasc Biol. 1997;17:64–71
  26. Reaven GM. Pathophysiology of insulin resistance in human disease. Physiol Rev. 1995;75:473–486
  27. Carlsson M, Wessman Y, Almgren P, Groop L. High levels of nonesterified fatty acids are associated with increased familial risk of cardiovascular disease. Arterioscler Thromb Vasc Biol. 2000;20:1588–1594
  28. Wolever TMS, Schrade KB, Vogt JA, Tsihlias EB, McBurney MI. Could colonic short chain fatty acids contribute to long-term adaptation of blood lipids on a high fiber diet in subjects with type 2 diabetes?. Am J Clin Nutr. 2002;75:1023–1030
  29. Stampfer MJ, Krauss RM, Ma J, Blanche PJ, Holl LG, Sacks FM, et al. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA. 1996;276:882–888
  30. Bredie SJ, de Bruin TW, Demacker PN, Kastelein JJ, Stalenhoef AF. Comparison of gemfibrozil versus simvastatin in familial combined hyperlipidemia and effects on apolipoprotein-B-containing lipoproteins, low-density lipoprotein subfraction profile, and low-density lipoprotein oxidizability. Am J Cardiol. 1995;75:348–353
  31. Pownall HJ, Brauchi D, Kilinç , Osmundsen K, Pao Q, Payton-Ross C, et al. Correlation of serum triglyceride and its reduction by ω-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteins. Atherosclerosis. 1999;132:285–297
  32. Chen YD, Coulston AM, Zhou MY, Hollenbeck CB, Reaven GM. Why do low-fat high-carbohydrate diets accentuate postprandial lipemia in patients with NIDDM?. Diabetes Care. 1995;18:10–16
  33. Hudgins LC, Hellerstein MK, Seidman CE, Neese RA, Tremaroli JD, Hirsch J. Relationship between carbohydrate-induced hypertriglyceridemia and fatty acid synthesis in lean and obese subjects. J Lipid Res. 2000;41:595–604
  34. Mittendorfer B, Sidossis LS. Mechanism for the increase in plasma triacylglycerol concentrations after consumption of short-term, high-carbohydrate diets. Am J Clin Nutr. 2001;73:892–899
  35. Garg A, Bonanome A, Grundy SM, Zhang ZJ, Unger RH. Comparison of a high-carbohydrate diet with a high-monounsaturated-fat diet in patients with non-insulin-dependent diabetes mellitus. New Eng J Med. 1988;319:829–834
  36. Jenkins DJA, Wolever TMS, Jenkins A, Brighenti F, Vuksan V, Rao AV, et al. Specific types of colonic fermentation may raise low-density-lipoprotein-cholesterol concentrations. Am J Clin Nutr. 1991;54:141–147
  37. Wolever TMS, Bentum-Williams A, Jenkins DJA. Physiologic modulation of plasma FFA concentrations by diet (metabolic implications in non-diabetic subjects). Diabetes Care. 1995;18:962–970
  38. Wolever TMS, Jenkins DJA, Vuksan V, Katzman L, Jenkins AL, Josse RG. Variation in meal fat does not affect the relative blood glucose response of spaghetti in subjects with type 2 diabetes. Diab Nutr Metab. 1992;5:191–197
  39. Arii K, Suehiro T, Yamamoto M, Ito H, Hashimoto K. Suppression of plasma cholesteryl ester transfer protein activity in acute hyperinsulinemia and effect of plasma nonesterified fatty acid. Metabolism. 1997;46:1166–1170
  40. Morton RE, Greene DJ. Suppression of lipid transfer inhibitor protein activity by oleate. A novel mechanism of cholesteryl ester transfer protein regulation by free fatty acids. Arterioscler Thromb Vasc Biol. 1997;17:3041–3048
  41. Hayek T, Azrolan N, Verdery RB, Walsh A, Chajek-Shaul T, Agellon LB, et al. Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism. Studies in transgenic mice. J Clin Invest. 1993;92:1143–1152
  42. Le NA, Gibson JC, Ginsberg HN. Independent regulation of plasma apolipoprotein C-II and C-III concentrations in very low density and high density lipoproteins (implications for the regulation of the catabolism of these lipoproteins). J Lipid Res. 1988;29:669–677
  43. Luc G, Fievet C, Arveiler D, Evans AE, Bard JM, Cambien F, et al. Apolipoproteins C-III and E in apoB- and non-apoB-containing lipoproteins in two populations at contrasting risk for myocardial infarction (the ECTIM study. Etude Cas Temoins sur ‘Infarctus du Myocarde). J Lipid Res. 1996;37:508–517
  44. Chen M, Breslow JL, Li W, Leff T. Transcriptional regulation of the apo C-III gene by insulin in diabetic mice (correlation with changes in plasma triglyceride levels). J Lipid Res. 1994;35:1918–1924
  45. Li WW, Dammerman MM, Smith JD, Metzger S, Breslow JL, Leff T. Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia. J Clin Invest. 1995;96:2601–2605
  46. Wolever TMS. Dietary carbohydrates and insulin action in humans. Brit J Nutr. 2000;8:3
  47. Fukagawa NK, Anderson JW, Hageman G, Young VR, Minaker KL. High-carbohydrate, high-fiber diets increase peripheral insulin sensitivity in healthy young and old adults. Am J Clin Nutr. 1990;52:524–528

PII: S0271-5317(02)00514-6

Nutrition Research
Volume 23, Issue 1 , Pages 15-26 , January 2003

Article Tools

* Image Usage & Resolution